Actuate Therapeutics Inc
ACTU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $155,337 | $129,440 | $129,440 |
| - Cash | $8,642 | $2,959 | $20,449 |
| + Debt | $0 | $0 | $405 |
| Enterprise Value | $146,695 | $126,482 | $109,396 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$25,161 | -$24,428 | -$20,080 |
| % Margin | – | – | – |
| Net Income | -$27,285 | -$24,745 | -$20,159 |
| % Margin | – | – | – |
| EPS Diluted | -3.26 | -1.65 | -1.34 |
| % Growth | -97.6% | -23.1% | – |
| Operating Cash Flow | -$21,843 | -$21,625 | -$17,794 |
| Capital Expenditures | $0 | $0 | $0 |
| Free Cash Flow | -$21,843 | -$21,625 | -$17,794 |